CClinicalTrials.gg
CompletedNCT05187468Updated Jan 11, 2022

The Effectiveness of Radial ESWT on Upper Trapezius Mtrps

An interventional study of Extracorporeal Shockwave Therapy and Extracorporeal Shockwave Therapy in Myofascial Pain Syndrome, Myofascial Trigger Point Pain and Upper Trapezius Trigger Points, sponsored by European University Cyprus. Completed at 1 site in Cyprus. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2022-01-11.

Sponsored by European University Cyprus · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 2 years 1 month after the study started (first participant enrolled Aug 2019, registered Sep 2021).
Phase
Not applicable
Study type
Interventional
Enrollment
56
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

This study looked after the effectiveness of radial ESWT on upper trapezius mtrps. There were three intervention groups which recieved either ESWT or standard care. VAS, PPT, Neck ROM and Cervical functionality were the main outcomes.

Read the detailed description

This study was a randomized controlled trial consisted of three intervention groups. Two of them recieved ESWT with different parameters in each group, while the third one was standard care recieving Ultrasound therapy, Therapeutic massage and Heat packs Participants were divided randomly into the three groups. Participants were blind to the group allocated and also the therapist and outcome investigator were blind.

The participants recieved three weekly sessions. The evaluation took place before therapy, after each session and one month after last session.

The outcome measures was the pain intensity with VAS, the pain tolerance to pressure by an algometer device, the range of motion of neck measured by electronic goniometer and and functionality of neck measured by the Northwick Park Neck Pain

02

Conditions studied

  • Myofascial Pain Syndrome
  • Myofascial Trigger Point Pain
  • Upper Trapezius Trigger Points

Keywords

  • Myofascial Trigger points
  • upper trapezius
  • Myofascial pain syndrome
  • Mtrps
03

In context

Myofascial Pain Syndromes

1,136 studies on the registry are indexed under Myofascial Pain Syndromes; 137 are open to participants now.

This study's enrollment of 56 is close to the median of 60 across 931 interventional studies indexed under Myofascial Pain Syndromes.

Browse Myofascial Pain Syndromes studies →

Lead sponsor

European University Cyprus is the lead sponsor of 15 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Pain between shoulder and neck on upper trapezius muscle
  • Three out of five of Travel and Simons criteria for myofascial trigger points

Exclusion criteria

Exclusion Criteria:

  • Fibromyalgia diagnosis
  • Systemic diseases diagnosis,
  • Pacemaker, under 18,
  • Any kind of cervical disorder or surgery,
  • Mental disorders
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Sequential assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
56 participants (actual)

Study arms

  • Experimental
    ESWT 1

    Extracorporeal Shockwave Therapy 1000 pulses, 60 mJ, 10 Hz

    Device: Extracorporeal Shockwave Therapy

  • Experimental
    ESWT 2

    Extracorporeal Shockwave Therapy 2000 pulses, 60 mJ, 10 Hz

    Device: Extracorporeal Shockwave Therapy

  • Active comparator
    Ultrasound therapy, Massage, Heat Pack

    10 Min massage 5 min US therapy 10 min Heat pack

    Device: Ultrasound therapy, Massage, Heat pack

Interventions

  • DeviceExtracorporeal Shockwave Therapy

    1000 pulses at 60 mj, 10 Hz

    Also known as: ESWT, rSWT

  • DeviceExtracorporeal Shockwave Therapy

    2000 pulses at 60 mj, 10 Hz

  • DeviceUltrasound therapy, Massage, Heat pack

    Ultrasound therapy 5 min, 1,2W/cm2, 10 min Massage, 10 min heat pack

06

What researchers measure

Primary outcomes

  1. Pain intensity on myofascial trigger points

    Visual Analogue Scale 1-10 (1 is the least pain, 10 is the worst pain)

    Time frame: baseline

  2. Pain intensity on myofascial trigger points

    Visual Analogue Scale 1-10 (1 is the least pain, 10 is the worst pain)

    Time frame: one week

  3. Pain intensity on myofascial trigger points

    Visual Analogue Scale 1-10 (1 is the least pain, 10 is the worst pain)

    Time frame: two weeks

  4. Pain intensity on myofascial trigger points

    Visual Analogue Scale 1-10 (1 is the least pain, 10 is the worst pain)

    Time frame: three weeks

  5. Pain intensity on myofascial trigger points

    Visual Analogue Scale 1-10 (1 is the least pain, 10 is the worst pain)

    Time frame: 1 month after

  6. Pressure Pain Threshold

    Pain tolerance to compression. Measured in kilos

    Time frame: baseline

  7. Pressure Pain Threshold

    Pain tolerance to compression. Measured in kilos

    Time frame: one week

  8. Pressure Pain Threshold

    Pain tolerance to compression. Measured in kilos

    Time frame: two weeks

  9. Pressure Pain Threshold

    Pain tolerance to compression. Measured in kilos

    Time frame: three weeks

  10. Pressure Pain Threshold

    Pain tolerance to compression. Measured in kilos

    Time frame: one month after

  11. cervical range of motion

    Goniometer (measured in degrees)

    Time frame: baseline

  12. cervical range of motion

    Goniometer (measured in degrees)

    Time frame: one week

  13. cervical range of motion

    Goniometer (measured in degrees)

    Time frame: two weeks

  14. cervical range of motion

    Goniometer (measured in degrees)

    Time frame: three weeks

  15. cervical range of motion

    Goniometer (measured in degrees)

    Time frame: one month after

  16. Northwick Park Neck Pain questionnaire

    functionality of Neck related to pain for daily activities. measured in % (36 questions). Higher the %, greater the disability

    Time frame: baseline

  17. Northwick Park Neck Pain questionnaire

    functionality of Neck related to pain for daily activities. measured in % (36 questions). Higher the %, greater the disability

    Time frame: one week

  18. Northwick Park Neck Pain questionnaire

    functionality of Neck related to pain for daily activities. measured in % (36 questions). Higher the %, greater the disability

    Time frame: two weeks

  19. Northwick Park Neck Pain questionnaire

    functionality of Neck related to pain for daily activities. measured in % (36 questions). Higher the %, greater the disability

    Time frame: three weeks

  20. Northwick Park Neck Pain questionnaire

    functionality of Neck related to pain for daily activities. measured in % (36 questions). Higher the %, greater the disability

    Time frame: one month after

07

Study locations

1 site
  • European University Cyprus
    Nicosia, 2404, Cyprus
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 11, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05187468
Lead sponsor
European University Cyprus
Responsible party
Rentzias Panagiotis (Lecturer, European University Cyprus) — Principal investigator
First posted
Jan 11, 2022
Start date
Aug 1, 2019
Primary completion
Oct 30, 2019
Completion
Feb 28, 2020
Last update
Jan 11, 2022

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion